晚期非小细胞肺癌患者同步放化疗期间肺功能的纵向评估
这项多中心前瞻性纵向研究纳入37例接受同步放化疗的局部晚期及寡转移非小细胞肺癌患者,用多种肺功能检查在基线及放化疗后6、12、24、48周评估肺功能。结果显示第1秒用力呼气容积24周最大下降31%(P=.008),一氧化碳弥散量12周下降21.8%(P=.002),并出现小气道功能障碍。作者认为肺功能检查可在临床症状出现前检出同步放化疗所致肺损伤。
要点
- 同步放化疗后24周第1秒用力呼气容积最大下降31%(P=.008)。
- 同步放化疗后48周用力肺活量下降9.6%(P=.04)、肺总量下降15.1%(P=.0015)。
- 同步放化疗后12周一氧化碳弥散量下降21.8%(P=.002),并见小气道功能障碍指标升高。
核心结论
- 通过肺功能检查对肺功能进行纵向评估,可在同步放化疗相关肺毒性所致临床症状出现之前检出同步放化疗引起的损伤。
研究设计与样本
- 多中心、前瞻性、纵向研究,纳入接受同步放化疗的局部晚期及寡转移非小细胞肺癌患者队列。
- 采用用力肺量计、体积描记法、脉冲振荡、一氧化碳弥散量、呼出气一氧化氮分数、动脉血气及6分钟步行试验,在基线、放疗后及同步放化疗后6、12、24、48周评估肺功能。
- 37例患者完成随访并纳入分析。
主要发现
- 同步放化疗后第1秒用力呼气容积于24周最大下降31%(P=.008)。
- 同步放化疗后用力肺活量于48周下降9.6%(P=.04)。
- 同步放化疗后肺总量于48周下降15.1%(P=.0015)。
- 同步放化疗后12周一氧化碳弥散量下降21.8%(P=.002)。
- 总气道阻力(5 Hz呼吸系统阻力)、阻力频率依赖性(5 Hz与20 Hz呼吸系统阻力之差,P=.012)及电抗(5 Hz呼吸系统电抗P=.0003、电抗面积P=.001)升高,共同提示小气道功能障碍。
关键数值与推荐
- 第1秒用力呼气容积24周较基线下降31%(P=.008)。
- 用力肺活量48周较基线下降9.6%(P=.04)。
- 肺总量48周较基线下降15.1%(P=.0015)。
- 一氧化碳弥散量12周较基线下降21.8%(P=.002)。
- 阻力频率依赖性P=.012,5 Hz呼吸系统电抗P=.0003,电抗面积P=.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In lung cancer patients, radiation therapy modifies lung architecture, resulting in functional deterioration, which worsens symptoms and reduces quality of life. METHODS AND MATERIALS: A multicenter, prospective, longitudinal study was conducted in a cohort of patients with locally advanced and oligometastatic non-small cell lung cancer treated with concurrent chemoradiation therapy (CCRT). A wide array of pulmonary function tests (forced spirometry, body plethysmography, impulse oscillometry, carbon monoxide diffusing capacity, fraction of exhaled nitric oxide, arterial blood gases, and 6-minute walk test) were used to evaluate lung function at baseline; after radiation therapy; and at 6, 12, 24, and 48 weeks after CCRT. Relative changes in test results (percentages) were estimated at the aforementioned intervals and compared with baseline results. RESULTS: Thirty-seven patients completed the follow-up and were included in the analysis. After CCRT, patients showed a maximum decline in lung volumes as follows: (1) 31% in forced expiratory volume in the first second after 24 weeks (P = .008), (2) 9.6% in forced vital capacity after 48 weeks (P = .04), and (3) 15.1% in total lung capacity after 48 weeks (P = .0015). Similarly, at 12 weeks after CCRT, patients showed a 21.8% decrease in carbon monoxide diffusing capacity (P = .002). Increases were found in total airway resistance (respiratory system resistance at 5 Hz), frequency dependence of resistance (change in respiratory system resistance at 5 Hz-respiratory system resistance at 20 Hz, P = .012), and reactance (P = .0003 for respiratory system reactance at 5 Hz and P = .001 for reactance area), which together indicate small-airway dysfunction. CONCLUSIONS: The longitudinal evaluation of lung function through pulmonary function tests detects CCRT-induced damage before the appearance of clinical symptoms associated with CCRT lung toxicity.
引用
- Torre-Bouscoulet L, Arroyo-Hernández M, Martínez-Briseño D, et al. Longitudinal Evaluation of Lung Function in Patients With Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 29976503. doi:10.1016/j.ijrobp.2018.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。